The Comparison of Levetiracetam and Piracetam efficacy on severe Breath Holding Spells

Phase 3

• Conditions: Breath holding spell.; Other abnormalities of breathing; R06.8

• Registration Number: IRCT20190208042654N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Patients with severe breath holding attacks at least 3 times a month
Aged less than 6 years and more than 6 months
Normal growth and development
Normal cardiovascular, cerebral and neurological examinations
Not having electrolyte disturbances, hypoglycemia and iron deficiency
Not having any seizure or neurological problem or epilepsy

Exclusion Criteria

Inability to follow up
occurrence of any drug reaction or any other problem during treatment
occurrence of seizure or any neurological disorders during the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of breath holding spells. Timepoint: Before the intervention and monthly up to 3 months. Method of measurement: Questionnaire.;Severity of breath holding spells: Percentage of convulsive attacks. Timepoint: Before the intervention and monthly up to 3 months. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
EEG pattern. Timepoint: Before the intervention and 3 months later. Method of measurement: Electroencephalography.